Liao, Y.-H.; Hsu, R.-J.; Wang, T.-H.; Wu, C.-T.; Huang, S.-Y.; Hsu, C.-Y.; Hsu, W.-L.; Liu, D.-W.
Aspirin and Primary Cancer Risk Reduction in Ischemic Cardiac or Cerebrovascular Disease Survivors: A Nationwide Population-Based Propensity-Matched Cohort Study. Cancers 2023, 15, 97.
https://doi.org/10.3390/cancers15010097
AMA Style
Liao Y-H, Hsu R-J, Wang T-H, Wu C-T, Huang S-Y, Hsu C-Y, Hsu W-L, Liu D-W.
Aspirin and Primary Cancer Risk Reduction in Ischemic Cardiac or Cerebrovascular Disease Survivors: A Nationwide Population-Based Propensity-Matched Cohort Study. Cancers. 2023; 15(1):97.
https://doi.org/10.3390/cancers15010097
Chicago/Turabian Style
Liao, Yen-Hsiang, Ren-Jun Hsu, Tzu-Hwei Wang, Chen-Ta Wu, Sheng-Yao Huang, Chung-Y. Hsu, Wen-Lin Hsu, and Dai-Wei Liu.
2023. "Aspirin and Primary Cancer Risk Reduction in Ischemic Cardiac or Cerebrovascular Disease Survivors: A Nationwide Population-Based Propensity-Matched Cohort Study" Cancers 15, no. 1: 97.
https://doi.org/10.3390/cancers15010097
APA Style
Liao, Y.-H., Hsu, R.-J., Wang, T.-H., Wu, C.-T., Huang, S.-Y., Hsu, C.-Y., Hsu, W.-L., & Liu, D.-W.
(2023). Aspirin and Primary Cancer Risk Reduction in Ischemic Cardiac or Cerebrovascular Disease Survivors: A Nationwide Population-Based Propensity-Matched Cohort Study. Cancers, 15(1), 97.
https://doi.org/10.3390/cancers15010097